Analysis of reported adverse events of pipeline stents for intracranial aneurysms using the FDA MAUDE database

OBJECTIVE: Flow diverting stents (FDS) are a validated device in the treatment of intracranial aneurysms, allowing for minimally invasive intervention. However, after its approval for use in the United States in 2011, post-market surveillance of adverse events is limited. This study aims to address...

Descripción completa

Detalles Bibliográficos
Autores principales: Porwal, Mokshal H., Kumar, Devesh, Thalner, Sharadhi, Hedayat, Hirad S., Sinson, Grant P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Cerebrovascular Surgeons and Korean NeuroEndovascular Society 2023
Materias:
Clinical Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555618/
https://www.ncbi.nlm.nih.gov/pubmed/36789489
http://dx.doi.org/10.7461/jcen.2023.E2022.10.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555618/
https://www.ncbi.nlm.nih.gov/pubmed/36789489
http://dx.doi.org/10.7461/jcen.2023.E2022.10.010

Ejemplares similares